Literature DB >> 33718157

The Biogenesis and Functions of circRNAs and Their Roles in Breast Cancer.

Liting Tang1, Baohong Jiang2, Hongbo Zhu1, Ting Gao1, Yu Zhou1, Fuqiang Gong1, Rongfang He3, Liming Xie1, Yuehua Li1,4.   

Abstract

Recent statistics show that breast cancer is among the most frequent cancers in clinical practice. It is also the second-leading cause of cancer-related deaths among women worldwide. CircRNAs are a new class of endogenous regulatory RNA molecules whose 5' end and 3' end are connected together to form a covalently closed single-stranded loop by back-splicing. CircRNAs present the advantages of disease-specific expression and excellent expression stability, and they can modulate gene expression at posttranscriptional and transcriptional levels. CircRNAs are abnormally expressed in multiple cancers, such as breast cancer, and drive the initiation and progression of cancer. In this review, we describe current knowledge about the functions of circRNAs and generalize their roles in various aspects of breast cancer, including cell proliferation, cell cycle, apoptosis, invasion and metastasis, autophagy, angiogenesis, drug resistance, and tumor immunity, and their prognostic and diagnostic value. This may add to a better understanding of the functions and roles of circRNAs in breast cancer, which may become new diagnostic and predictive biomarkers of breast cancer.
Copyright © 2021 Tang, Jiang, Zhu, Gao, Zhou, Gong, He, Xie and Li.

Entities:  

Keywords:  apoptosis; biomarkers; breast cancer; cell proliferation; circRNA; drug resistance; prognosis

Year:  2021        PMID: 33718157      PMCID: PMC7947672          DOI: 10.3389/fonc.2021.605988

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  102 in total

Review 1.  Circular RNA: A new star of noncoding RNAs.

Authors:  Shibin Qu; Xisheng Yang; Xiaolei Li; Jianlin Wang; Yuan Gao; Runze Shang; Wei Sun; Kefeng Dou; Haimin Li
Journal:  Cancer Lett       Date:  2015-06-05       Impact factor: 8.679

2.  circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer.

Authors:  Yuting Sang; Bing Chen; Xiaojin Song; Yaming Li; Yiran Liang; Dianwen Han; Ning Zhang; Hanwen Zhang; Ying Liu; Tong Chen; Chen Li; Lijuan Wang; Wenjing Zhao; Qifeng Yang
Journal:  Mol Ther       Date:  2019-05-17       Impact factor: 11.454

Review 3.  Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment.

Authors:  Ana C Garrido-Castro; Nancy U Lin; Kornelia Polyak
Journal:  Cancer Discov       Date:  2019-01-24       Impact factor: 39.397

4.  Screening circular RNA related to chemotherapeutic resistance in breast cancer.

Authors:  Danfeng Gao; Xiufen Zhang; Beibei Liu; Dong Meng; Kai Fang; Zijian Guo; Lihua Li
Journal:  Epigenomics       Date:  2017-08-14       Impact factor: 4.778

Review 5.  ncRNA-Encoded Peptides or Proteins and Cancer.

Authors:  Jizhong Wang; Song Zhu; Nan Meng; Yutian He; Ruixun Lu; Guang-Rong Yan
Journal:  Mol Ther       Date:  2019-09-06       Impact factor: 11.454

Review 6.  Characterization and Function of Circular RNAs in Plants.

Authors:  Peijing Zhang; Sida Li; Ming Chen
Journal:  Front Mol Biosci       Date:  2020-05-19

7.  Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia.

Authors:  Shasha Ren; Jiuzhou Liu; Yun Feng; Zhenyu Li; Liang He; Leilei Li; Xiaozhong Cao; Zhenghua Wang; Yanwu Zhang
Journal:  J Exp Clin Cancer Res       Date:  2019-09-05

8.  UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer.

Authors:  Jing He; Yuanping Chen; Lu Cai; Zelei Li; Xiaoqing Guo
Journal:  Breast Cancer       Date:  2017-12-01       Impact factor: 4.239

9.  Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway.

Authors:  Ping Yang; Zhijun Qiu; Yuan Jiang; Lei Dong; Wensheng Yang; Chao Gu; Guang Li; Yu Zhu
Journal:  Oncotarget       Date:  2016-09-27

10.  pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer.

Authors:  Sipei Zhang; Nan Guo; Guoyun Wan; Tao Zhang; Chunyu Li; Yongfei Wang; Yinsong Wang; Yuanyuan Liu
Journal:  J Nanobiotechnology       Date:  2019-10-17       Impact factor: 10.435

View more
  6 in total

Review 1.  The value of exosome-derived noncoding RNAs in colorectal cancer proliferation, metastasis, and clinical applications.

Authors:  Wenjie Zhang; Zhengting Jiang; Dong Tang
Journal:  Clin Transl Oncol       Date:  2022-08-03       Impact factor: 3.340

2.  CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review.

Authors:  Zahra Foruzandeh; Fatemeh Zeinali-Sehrig; Kazem Nejati; Dara Rahmanpour; Fariba Pashazadeh; Farhad Seif; Mohammad Reza Alivand
Journal:  Cell Mol Biol Lett       Date:  2021-09-23       Impact factor: 5.787

3.  EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by regulating WBP2 and PI3K/AKT signaling pathway.

Authors:  Xuehui Wang; Hongming Song; Lin Fang; Tianqi Wu
Journal:  Cell Death Discov       Date:  2022-03-02

Review 4.  Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma.

Authors:  Hai-Long Li; Nian-Hua Deng; Xiu-Sheng He; Yue-Hua Li
Journal:  Biomark Res       Date:  2022-07-26

5.  CircEPSTI1 Promotes the Proliferation of HER2-Positive Breast Cancer Cells via circEPSTI1/miR-145/ERBB3 Axis.

Authors:  Yue Zhang; Duxun Tan; Yi Xie; Linyu Wu; Song Wu; Yuhui Tang; Yongzhou Luo; Xiangsheng Xiao; Xing Li
Journal:  J Oncol       Date:  2022-08-26       Impact factor: 4.501

6.  Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation.

Authors:  Hong Lin; Fangyi Long; Xiqian Zhang; Pinghan Wang; Ting Wang
Journal:  Front Mol Biosci       Date:  2022-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.